MedTrace Logo

Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer

NCT05235750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-03-17

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to learn if a brief writing intervention works to improve quality of life outcomes in adult patients newly diagnosed with advanced stage cancer.

Conditions

  • Neoplasms

Interventions

BEHAVIORAL

Self-affirmation writing

Writing with a focus on self-affirmation at the time following a diagnosis of an advanced cancer

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Mei Bai, Ph.D. · University of Arkansas

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-27
Primary Completion
2023-07-07
Completion
2023-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235750 on ClinicalTrials.gov